Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference7 articles.
1. Barrett, A. Pfizer's Funk. Business Week, February 28, 2005, p. 72.
http://www.businessweek.com/magazine/content/05_09/b3922001_mz001.htm
2. McKinnon, R. et al. Crisis? What Crisis? A Fresh Diagnosis of Big Pharma's R&D Productivity Crunch (Marakon Associates, NY, 2004).
http://www.marakon.com/ideas_pdf/id_041104_mckinnon.pdf
3. Thiel, K. Goodbye, Columbus! New NRDOs forego discovery. Nat. Biotechnol. 22, 1087–1092 (2004).
4. Villiger, R. & Bogdan, B. Getting real about valuations in biotech. Nat. Biotechnol. 23, 423–428 (2005).
5. DiMasi, J.A. et al. The price of innovation: new estimates of drug development costs. J. Health Economics 22, 151–185 (2003).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献